Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

 Desmopressin Monoacetate Taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Desmopressin Monoacetate Manufacturers in India Suppliers Desmopressin Monoacetate Exporters Distributors Desmopressin Monoacetate api active pharmaceuticals ingredients Desmopressin Monoacetate manufacturers Side Effects bulk drugs raw material Desmopressin Monoacetate companies Side Effects Importers Desmopressin Monoacetate Desmopressin Monoacetate Exporters Desmopressin Monoacetate exporters FDA Desmopressin Monoacetate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Desmopressin Monoacetate manufacturing pharmaceutical drugs pharmaceutical intermediates Desmopressin Monoacetate pharmaceutical chemicals pharmaceutical raw materials Desmopressin Monoacetate active pharmaceutical ingredients Desmopressin Monoacetate committee active pharmaceutical ingredients manufacturer Desmopressin Monoacetate Active Pharmaceutical Ingredients manufacturer Desmopressin Monoacetate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Desmopressin Monoacetate, Desmopressin Monoacetate manufacturer India, Desmopressin Monoacetate product, Desmopressin Monoacetate products, Api preparation, Certificate of Analysis API manufacturer product, Desmopressin Monoacetate anti ulcer product, Certificate of Origin COA Desmopressin Monoacetate COS Desmopressin Monoacetate, pharmaceutical generic, pharmaceutical drug, medical, Desmopressin Monoacetate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Desmopressin Monoacetate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Desmopressin Monoacetate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Desmopressin Monoacetate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Desmopressin Monoacetate ingredients, api, HIV Desmopressin Monoacetate, tablets, capsules, syrup & protein Desmopressin Monoacetate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Desmopressin Monoacetate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Desmopressin Monoacetate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Desmopressin


 



















 

 

 






 

 

HOME >> API >> API List1 >> Desmopressin Monoacetate >> Pharmalogy

Desmopressin Monoacetate CAS Number 62288-83-9


PHARMALOGY
Desmopressin Monoacetate CAS Number
62288-83-9

Desmopressin Monoacetate Tablets contain as active substance, desmopressin acetate, a synthetic analogue of the natural hormone arginine vasopressin.

Central Diabetes Insipidus: Dose response studies in patients with diabetes insipidus have demonstrated that oral doses of 0.025 mg to 0.4 mg produced clinically significant antidiuretic effects. In most patients, doses of 0.1 mg to 0.2 mg produced optimal antidiuretic effects lasting up to eight hours. With doses of 0.4 mg, antidiuretic effects were observed for up to 12 hours; measurements beyond 12 hours were not recorded. Increasing oral doses produced dose dependent increases in the plasma levels of Desmopressin Monoacetate
The bioavailability of Desmopressin Monoacetate oral tablets is about 5% compared to intranasal Desmopressin Monoacetate, and about 0.16% compared to intravenous Desmopressin Monoacetate. The time to reach maximum plasma Desmopressin Monoacetate levels ranged from 0.9 to 1.5 hours following oral or intranasal administration, respectively. Following administration of Desmopressin Monoacetate Tablets, the onset of antidiuretic effect occurs at around 1 hour, and it reaches a maximum at about 4 to 7 hours based on the measurement of increased urine osmolality.he use of Desmopressin Monoacetate Tablets in patients with an established diagnosis will result in a reduction in urinary output with an accompanying increase in urine osmolality. These effects usually will allow resumption of a more normal life style, with a decrease in urinary frequency and nocturia.There are reports of an occasional change in response to the intranasal formulations of Desmopressin Monoacetate (Desmopressin Monoacetate Nasal Spray and Desmopressin Monoacetate Rhinal Tube). Usually, the change occurred over a period of time greater than six months. This change may be due to decreased responsiveness, or to shortened duration of effect. There is no evidence that this effect is due to the development of binding antibodies, but may be due to a local inactivation of the peptide. No lessening of effect was observed in the 46 patients who were treated with Desmopressin Monoacetate Tablets for 12 to 44 months and no serum antibodies to desmopressin were detected.The change in structure of arginine vasopressin to desmopressin acetate resulted in less vasopressor activity and decreased action on visceral smooth muscle relative to enhanced antidiuretic activity. Consequently, clinically effective antidiuretic doses are usually below the threshold for effects on vascular or visceral smooth muscle. In the four long-term studies of Desmopressin Monoacetate Tablets, no increases in blood pressure in 46 patients receiving Desmopressin Monoacetate Tablets for periods of 12 to 44 months were reported.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
PHARMALOGY >>
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Desmopressin Monoacetate

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.